Cargando…
Paclitaxel-Based Chemotherapy Targeting Cancer Stem Cells from Mono- to Combination Therapy
Paclitaxel (PTX) is a chemotherapeutical agent commonly used to treat several kinds of cancer. PTX is known as a microtubule-targeting agent with a primary molecular mechanism that disrupts the dynamics of microtubules and induces mitotic arrest and cell death. Simultaneously, other mechanisms have...
Autores principales: | Nawara, Hend M., Afify, Said M., Hassan, Ghmkin, Zahra, Maram H., Seno, Akimasa, Seno, Masaharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147479/ https://www.ncbi.nlm.nih.gov/pubmed/34063205 http://dx.doi.org/10.3390/biomedicines9050500 |
Ejemplares similares
-
Paclitaxel and Sorafenib: The Effective Combination of Suppressing the Self-Renewal of Cancer Stem Cells
por: Nawara, Hend M., et al.
Publicado: (2020) -
GSK-3α/β and MEK inhibitors assist the microenvironment of tumor initiation
por: Hassan, Ghmkin, et al.
Publicado: (2023) -
The significance of ErbB2/3 in the conversion of induced pluripotent stem cells into cancer stem cells
por: Hassan, Ghmkin, et al.
Publicado: (2022) -
Cancer stem cells induced by chronic stimulation with prostaglandin E2 exhibited constitutively activated PI3K axis
por: Minematsu, Hideki, et al.
Publicado: (2022) -
Differentiation of cancer stem cells into erythroblasts in the presence of CoCl(2)
por: Kumon, Kazuki, et al.
Publicado: (2021)